Spermosens AB is a manufacturer based in Lund that specializes in developing innovative diagnostics aimed at addressing male-factor infertility. The company focuses on guiding patients toward appropriate infertility treatments, utilizing a breakthrough platform technology designed to enhance diagnostic capabilities. Their JUNO-CHECKED® technology is a key feature that supports improved diagnostic accuracy in the context of male infertility.
In addition to its diagnostic services, Spermosens AB is committed to providing educational resources through its ART Academy. This initiative aims to inform and empower patients and healthcare professionals about the complexities of male infertility and the available treatment options. The company emphasizes collaboration within the in vitro fertilization (IVF) process, striving to improve outcomes for individuals facing male infertility challenges.
Spermosens AB places a strong emphasis on patient privacy and data protection, ensuring that users' information is handled securely. The organization aims to revolutionize the diagnosis and treatment of male infertility, reflecting its commitment to advancing healthcare solutions in this area.